Novel exon-exon breakpoint in CIC-DUX4 fusion sarcoma identified by anchored multiplex PCR (Archer FusionPlex Sarcoma Panel)

J Clin Pathol. 2017 Aug;70(8):697-701. doi: 10.1136/jclinpath-2016-204247. Epub 2017 Jan 30.

Abstract

Aims: We describe the clinical and pathological features and novel genetic findings of a case of CIC-DUX4 sarcoma occurring in the thigh of a 35-year-old man.

Methods: Fusion gene detection using a next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) was used to identify the novel fusion breakpoints of this CIC-DUX4 sarcoma using formalin-fixed and paraffin-embedded tumour material.

Results: This CIC-DUX4 sarcoma has a novel fusion breakpoint between exon 20 of the CIC gene and exon 1 of the DUX4 gene.

Conclusions: This case report describes an additional case of CIC-DUX4 sarcoma with a novel fusion breakpoint, and demonstrates the value of this next-generation sequencing-based anchored multiplex PCR technique (Archer FusionPlex Sarcoma Panel) in both diagnosis for patient care and in identification of a novel fusion breakpoint in this tumour type.

Keywords: CANCER; MOLECULAR PATHOLOGY; SARCOMAS.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • DNA Breaks
  • Exons / genetics*
  • Fatal Outcome
  • Homeodomain Proteins / genetics*
  • Humans
  • Male
  • Multiplex Polymerase Chain Reaction
  • Neoplasms, Muscle Tissue / genetics*
  • Neoplasms, Muscle Tissue / pathology
  • Oncogene Proteins, Fusion / genetics
  • Repressor Proteins / genetics*
  • Sarcoma / genetics*
  • Sarcoma / pathology
  • Thigh
  • Translocation, Genetic / genetics

Substances

  • CIC protein, human
  • DUX4L1 protein, human
  • Homeodomain Proteins
  • Oncogene Proteins, Fusion
  • Repressor Proteins